← Leaderboards
Paul Yang
Oregon Health & Science University
$1,062,960
Attributed
$1,062,960
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $212.6K · FY2016–20$250K$187.5K$125K$62.5K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,062,960 · 1
By mechanism
K08$1,062,960 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jeffrey Wallace Tyner$13,872,769
- Summer Lynne Gibbs$14,875,792
- Hui Wu$19,750,423
- Gail Mandel$12,042,469
- Rebecca Lynn Williams$219,720
Others in their field
Top investigators on “Adverse Drug Effect”
- Elizabeth A Thom · George Washington University$121,387,653
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- John M Lachin · George Washington University$118,921,924
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,372,214
- Myron S Cohen · Family Health International$101,800,876
Research focus
Adverse Drug EffectFoundationsAnimalsAppearanceFda ApprovedBench To BedsideBlindnessCareer DevelopmentCell CountCell DeathAwardAnimal ModelClinical TrialsConduct Clinical TrialsCyclic GmpCytokineCytotoxicityDiagnosisDoctor Of PhilosophyDoseEnvironmentEnzyme-Linked Immunosorbent AssayEtiologyFunding
Grant awards (5)
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis Pigmentosa$212,592
K08 · FY2020 · EY · contact PI
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis Pigmentosa$212,592
K08 · FY2019 · EY · contact PI
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis Pigmentosa$212,592
K08 · FY2018 · EY · contact PI
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis Pigmentosa$212,592
K08 · FY2017 · EY · contact PI
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis Pigmentosa$212,592
K08 · FY2016 · EY · contact PI